Prognostic Significance of a Systemic Inflammatory Response in Patients Undergoing Multimodality Therapy for Advanced Colorectal Cancer-Reference-Cited by-同舟云学术

Prognostic Significance of a Systemic Inflammatory Response in Patients Undergoing Multimodality Therapy for Advanced Colorectal Cancer

Published:2013 Issue:2 Volume:84 Page:100-107
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Inoue Yasuhiro,Iwata Takashi,Okugawa Yoshinaga,Kawamoto Aya,Hiro Junichiro,Toiyama Yuji,Tanaka Koji,Uchida Keiichi,Mohri Yasuhiko,Miki Chikao,Kusunoki Masato

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference28 articles.

1. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

2. Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest

3. Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

4. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

5. Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Systemic Inflammatory Markers and Scoring Systems in Predicting Postoperative 30-Day Complications and Mortality in Colorectal Cancer Surgery: A Retrospective Cross-Sectional Analysis;Annali Italiani di Chirurgia;2024-08-20

2. Clinical Impact of Nutrition and Inflammation Assessment Tools in Colorectal Cancer Treatment;Anticancer Research;2024-03-27

3. The Clinical Benefit of the Modified Neutrophil-Platelet Score as a Surrogate Prognostic Marker in Patients With Resectable Gastric Cancer;In Vivo;2024

4. Importance of the neutrophil–lymphocyte ratio and systemic immune‐inflammation index in predicting colorectal pathologies in fecal occult blood‐positive patients;Journal of Clinical Laboratory Analysis;2023-04

5. Preoperative CRP (−) /CEA (−) /CA19-9 (−) /non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence;Journal of the Anus, Rectum and Colon;2022-10-27